- Home
- OCS vs OPY Comparison
OCS vs OPY Comparison
Compare OCS & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCS
- OPY
- Stock Information
- Founded
- OCS 2003
- OPY 1881
- Country
- OCS Switzerland
- OPY United States
- Employees
- OCS N/A
- OPY N/A
- Industry
- OCS Biotechnology: Pharmaceutical Preparations
- OPY Investment Bankers/Brokers/Service
- Sector
- OCS Health Care
- OPY Finance
- Exchange
- OCS Nasdaq
- OPY Nasdaq
- Market Cap
- OCS 956.4M
- OPY 766.7M
- IPO Year
- OCS N/A
- OPY N/A
- Fundamental
- Price
- OCS $17.34
- OPY $78.83
- Analyst Decision
- OCS Strong Buy
- OPY
- Analyst Count
- OCS 4
- OPY 0
- Target Price
- OCS $35.75
- OPY N/A
- AVG Volume (30 Days)
- OCS 14.2K
- OPY 50.8K
- Earning Date
- OCS 11-06-2025
- OPY 10-24-2025
- Dividend Yield
- OCS N/A
- OPY 0.92%
- EPS Growth
- OCS N/A
- OPY 41.03
- EPS
- OCS N/A
- OPY 7.71
- Revenue
- OCS $960,668.00
- OPY $1,400,370,000.00
- Revenue This Year
- OCS $11.49
- OPY N/A
- Revenue Next Year
- OCS $1,784.02
- OPY N/A
- P/E Ratio
- OCS N/A
- OPY $9.94
- Revenue Growth
- OCS N/A
- OPY 14.40
- 52 Week Low
- OCS $11.78
- OPY $47.39
- 52 Week High
- OCS $23.08
- OPY $79.32
- Technical
- Relative Strength Index (RSI)
- OCS 48.91
- OPY 67.55
- Support Level
- OCS $16.94
- OPY $70.50
- Resistance Level
- OCS $17.34
- OPY $77.50
- Average True Range (ATR)
- OCS 0.40
- OPY 2.17
- MACD
- OCS 0.08
- OPY 0.62
- Stochastic Oscillator
- OCS 73.35
- OPY 95.01
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
About OPY Oppenheimer Holdings Inc. (DE)
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.